Chimin Health Management Co., Ltd. Class ASSE: 603222

Announcement on Obtaining Notice of Approval for Drug Clinical Trial by the Holding Subsidiary’s Pharmaceuticals

· Issued by Chimin Health Management Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trial by the Holding Subsidiary’s Pharmaceuticals

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment